Compare TKO & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKO | BAX |
|---|---|---|
| Founded | 1980 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 13.9B |
| IPO Year | 2023 | 1994 |
| Metric | TKO | BAX |
|---|---|---|
| Price | $182.69 | $23.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 9 |
| Target Price | ★ $224.53 | $21.00 |
| AVG Volume (30 Days) | 902.4K | ★ 5.7M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.70% | 0.24% |
| EPS Growth | ★ 11200.00 | N/A |
| EPS | ★ 2.46 | 0.21 |
| Revenue | $4,735,151,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $23.14 | $1.96 |
| Revenue Next Year | $1.05 | $2.22 |
| P/E Ratio | ★ $75.23 | $111.81 |
| Revenue Growth | ★ 68.85 | 5.72 |
| 52 Week Low | $176.00 | $15.73 |
| 52 Week High | $226.94 | $30.00 |
| Indicator | TKO | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 39.29 |
| Support Level | $181.70 | $21.28 |
| Resistance Level | $214.84 | $23.62 |
| Average True Range (ATR) | 5.67 | 0.70 |
| MACD | -0.68 | -0.07 |
| Stochastic Oscillator | 14.15 | 26.80 |
TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.